{"count":10,"index":{"built_at":"2026-07-27T23:33:40.856410+00:00","public_records":55311,"revision":"2965aee17465f8a8f5f001f7"},"query":{"area":null,"kind":null,"lang":null,"limit":10,"match_mode":"all_terms","q":"Evidence check: TCF7L2 in the context of Blutzucker"},"results":[{"answer":"TCF7L2 is one of the strongest genetic loci associated with type 2 diabetes. Variants (e.g., rs7903146) increase risk for impaired glucose tolerance and fasting blood glucose, primarily through reduced insulin secretion. Effect size is moderate (odds ratio ~1.4 per risk allele), but penetrance is low: many carriers never develop diabetes. The association is confirmed in numerous GWAS and meta-analyses (human-strong). However, the predictive value of a single SNP for individual blood sugar is limited; lifestyle, diet, and other genetic factors dominate. MyBody-X is not a diagnostic tool – elevated genetic risk should prompt medical check-ups (e.g., HbA1c, OGTT), not self-treatment. Evidence comes from population studies, not clinical interventions. Caveat: effects vary by ancestry (best studied in European cohorts).","area":"gesundheit","canonical_id":"gesundheit:canonical-88716d0dcc337a232e014d4a","id":"public-346edc2162f2f90916638c44","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Evidence check: TCF7L2 in the context of Blutzucker","score":21.1947996,"snippet":"TCF7L2 is one of the strongest genetic loci associated with type 2 diabetes. Variants (e.g., rs7903146) increase risk for impaired glucose tolerance and fasting blood glucose, primarily through reduced insulin secretion. Effect size is moderate (odds ratio ~1.4 per risk allele), but penetrance is low: many carriers never develop diabetes. The association is confirmed in numerous GWAS and meta-analyses (human-strong). However, the predictive value of a single SNP for individual blood sugar is limited; lifestyle, diet, and other genetic factors dominate. MyBody-X is not a diagnostic tool – elevated genetic risk should prompt medical check-ups (e.g., HbA1c, OGTT), not self-treatment. Evidence c","sources":[],"title":"Evidence check: TCF7L2 in the context of Blutzucker","url":"https://tikki.wiki/wissen/gesundheit/frage/public-346edc2162f2f90916638c44/evidence-check-tcf7l2-in-the-context-of-blutzucker/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"The MyBody-X DNA Nutrition Test analyzes genetic variants linked to carbohydrate metabolism (e.g., TCF7L2, GCKR) and glycemic response. The underlying evidence comes from GWAS and observational studies showing small effect sizes – for instance, carriers of the TCF7L2 rs7903146 T-allele may respond better to a low-fat, high-carb diet. However, results are conflicting (e.g., the DIETFITS trial found no genotype-diet interaction). The test is designed for lifestyle inspiration, not medical diagnosis. For weight loss, calorie balance, exercise, sleep, and stress play far larger roles than individual gene variants. Effect sizes are small, and data are often limited to European populations. There is no clinical validation for weight reduction. Therefore, the test is insufficient for anyone seeking concrete medical or nutritional decisions. It may serve as an extra nudge toward a healthier lifestyle but does not replace professional medical or dietary advice. Caution: Do not use for disease screening or treatment planning.","area":"gesundheit","canonical_id":"gesundheit:canonical-8be28cc0440a4ac1047d3377","id":"public-9769fb0ee80650e44c20a4e4","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Evidence check: Fitness | LifestyleCheck in the context of Blutzucker","score":20.33482107,"snippet":"The MyBody-X DNA Nutrition Test analyzes genetic variants linked to carbohydrate metabolism (e.g., TCF7L2, GCKR) and glycemic response. The underlying evidence comes from GWAS and observational studies showing small effect sizes – for instance, carriers of the TCF7L2 rs7903146 T-allele may respond better to a low-fat, high-carb diet. However, results are conflicting (e.g., the DIETFITS trial found no genotype-diet interaction). The test is designed for lifestyle inspiration, not medical diagnosis. For weight loss, calorie balance, exercise, sleep, and stress play far larger roles than individual gene variants. Effect sizes are small, and data are often limited to European populations. There ","sources":[],"title":"Evidence check: Fitness | LifestyleCheck in the context of Blutzucker","url":"https://tikki.wiki/wissen/gesundheit/frage/public-9769fb0ee80650e44c20a4e4/evidence-check-fitness-lifestylecheck-in-the-context-of-blutzucker/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"APOA2 encodes apolipoprotein A-II, a component of HDL. Some GWAS have linked certain APOA2 variants (e.g., rs5082) to fasting glucose or insulin resistance, but effect sizes are small and replication inconsistent. The evidence is primarily associative (GWAS), not causal. For blood sugar control, lifestyle factors and well-established genes like TCF7L2 or GCKR are far more relevant. A DNA test for APOA2 alone does not provide clinically actionable information. Caveat: current evidence is too weak for recommendations. Anyone aiming to optimize blood sugar should rely on standard biomarkers (HbA1c, fasting glucose) and medical guidance.","area":"gesundheit","canonical_id":"gesundheit:canonical-eeff290b5ca0591cb8119f6d","id":"public-b62acf5ae28cfb3c2f052037","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Evidence check: APOA2 in the context of Blutzucker","score":19.97044186,"snippet":"APOA2 encodes apolipoprotein A-II, a component of HDL. Some GWAS have linked certain APOA2 variants (e.g., rs5082) to fasting glucose or insulin resistance, but effect sizes are small and replication inconsistent. The evidence is primarily associative (GWAS), not causal. For blood sugar control, lifestyle factors and well-established genes like TCF7L2 or GCKR are far more relevant. A DNA test for APOA2 alone does not provide clinically actionable information. Caveat: current evidence is too weak for recommendations. Anyone aiming to optimize blood sugar should rely on standard biomarkers (HbA1c, fasting glucose) and medical guidance.","sources":[],"title":"Evidence check: APOA2 in the context of Blutzucker","url":"https://tikki.wiki/wissen/gesundheit/frage/public-b62acf5ae28cfb3c2f052037/evidence-check-apoa2-in-the-context-of-blutzucker/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"The provided context does not contain any information linking VKORC1 to blood sugar (Blutzucker). VKORC1 is primarily known for its role in vitamin K metabolism and warfarin sensitivity. There is no established direct relationship between VKORC1 variants and glucose homeostasis in the current evidence base. While some studies have explored vitamin K and insulin sensitivity, these are not specific to VKORC1 and are not mentioned in the context. Therefore, any claim of a VKORC1-blood sugar link is not supported by the provided knowledge. Consumers should be cautious of marketing claims that overinterpret genetic data. For personalized nutrition advice, validated markers like TCF7L2 (for type 2 diabetes risk) or continuous glucose monitoring are more appropriate. Evidence: unclear.","area":"gesundheit","canonical_id":"gesundheit:canonical-5a2f5ddd6c325f76ac997290","id":"public-3696c8cf6c01951a7005bd1a","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Evidence check: VKORC1 in the context of Blutzucker","score":19.86258083,"snippet":"The provided context does not contain any information linking VKORC1 to blood sugar (Blutzucker). VKORC1 is primarily known for its role in vitamin K metabolism and warfarin sensitivity. There is no established direct relationship between VKORC1 variants and glucose homeostasis in the current evidence base. While some studies have explored vitamin K and insulin sensitivity, these are not specific to VKORC1 and are not mentioned in the context. Therefore, any claim of a VKORC1-blood sugar link is not supported by the provided knowledge. Consumers should be cautious of marketing claims that overinterpret genetic data. For personalized nutrition advice, validated markers like TCF7L2 (for type 2","sources":[],"title":"Evidence check: VKORC1 in the context of Blutzucker","url":"https://tikki.wiki/wissen/gesundheit/frage/public-3696c8cf6c01951a7005bd1a/evidence-check-vkorc1-in-the-context-of-blutzucker/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"MTHFR variants (C677T, A1298C) affect folate metabolism and homocysteine levels. Some studies suggest elevated homocysteine may contribute to insulin resistance, indirectly influencing blood sugar. However, the evidence is weak, inconsistent, and mostly from association studies (GWAS) or mechanistic work. Direct, clinically relevant effects on fasting glucose or HbA1c are not established. Many direct-to-consumer tests overstate MTHFR's role in metabolic disease. Caveat: MTHFR is not a strong predictor of blood sugar issues; lifestyle, diet, exercise, and other genetic factors (e.g., TCF7L2) dominate. Blood homocysteine measurement may be useful, but genotyping alone does not justify specific glucose-lowering interventions. The provided context sources contain no direct studies on MTHFR and blood sugar.","area":"gesundheit","canonical_id":"gesundheit:canonical-3efed64f0936c24710bdad2b","id":"public-5aadd40f13ee819a3fcad474","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Evidence check: MTHFR in the context of Blutzucker","score":19.84862964,"snippet":"MTHFR variants (C677T, A1298C) affect folate metabolism and homocysteine levels. Some studies suggest elevated homocysteine may contribute to insulin resistance, indirectly influencing blood sugar. However, the evidence is weak, inconsistent, and mostly from association studies (GWAS) or mechanistic work. Direct, clinically relevant effects on fasting glucose or HbA1c are not established. Many direct-to-consumer tests overstate MTHFR's role in metabolic disease. Caveat: MTHFR is not a strong predictor of blood sugar issues; lifestyle, diet, exercise, and other genetic factors (e.g., TCF7L2) dominate. Blood homocysteine measurement may be useful, but genotyping alone does not justify specific","sources":[],"title":"Evidence check: MTHFR in the context of Blutzucker","url":"https://tikki.wiki/wissen/gesundheit/frage/public-5aadd40f13ee819a3fcad474/evidence-check-mthfr-in-the-context-of-blutzucker/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"The NutriCare INFINITY DNA Test marketed for blood sugar (Blutzucker) claims to provide personalized dietary advice based on genetic variants. However, the scientific evidence is limited. While GWAS have identified variants in genes like TCF7L2 and GCKR associated with fasting glucose and type 2 diabetes risk, their effect sizes are small and not clinically actionable for most individuals. Blood sugar regulation is predominantly influenced by lifestyle factors (diet, exercise, weight, stress). The test lacks clinical validation for diagnosis or personalized nutrition guidance. It should not replace standard medical tests (e.g., HbA1c, OGTT). Evidence level: GWAS associations with weak predictive value, often overhyped in marketing. Caution: Do not adjust medications based solely on such consumer genetic results without professional oversight.","area":"gesundheit","canonical_id":"gesundheit:canonical-c0ae49b99e82b3672007ca96","id":"public-e5c6ee67aeb4f8ff02a6c417","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Evidence check: NutriCare | INFINITY DNA-Test in the context of Blutzucker","score":19.79103286,"snippet":"The NutriCare INFINITY DNA Test marketed for blood sugar (Blutzucker) claims to provide personalized dietary advice based on genetic variants. However, the scientific evidence is limited. While GWAS have identified variants in genes like TCF7L2 and GCKR associated with fasting glucose and type 2 diabetes risk, their effect sizes are small and not clinically actionable for most individuals. Blood sugar regulation is predominantly influenced by lifestyle factors (diet, exercise, weight, stress). The test lacks clinical validation for diagnosis or personalized nutrition guidance. It should not replace standard medical tests (e.g., HbA1c, OGTT). Evidence level: GWAS associations with weak predic","sources":[],"title":"Evidence check: NutriCare | INFINITY DNA-Test in the context of Blutzucker","url":"https://tikki.wiki/wissen/gesundheit/frage/public-e5c6ee67aeb4f8ff02a6c417/evidence-check-nutricare-infinity-dna-test-in-the-context-of-blutzucker/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"Pharmacogenetics in the context of blood sugar focuses on genetic variants that influence response to diabetes medications. Key examples include TCF7L2 (metformin response), KCNJ11 (sulfonylureas), and CYP2C9 (sulfonylurea metabolism). Evidence from GWAS and clinical studies shows moderate effect sizes – for instance, metformin efficacy can vary by 20–30% depending on genotype. However, clinical implementation is not yet routine because the effects are small and often overshadowed by lifestyle, diet, and comorbidities. A commercial 'Pharmacogenetics Medicheck' can offer hypotheses but cannot replace medical diagnosis or treatment decisions. Predictive power for individual blood sugar trajectories is limited. Moreover, many tests lack sufficient validation or are ancestry-specific. Patients should discuss results with a physician before altering medications. Overall, the evidence is moderate but insufficient for routine use in the general population.","area":"gesundheit","canonical_id":"gesundheit:canonical-edb7bc4b318c1d1f4fd72a0f","id":"public-0eebbcb43fe140c7b4291485","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Evidence check: Pharmakogenetik Medicheck in the context of Blutzucker","score":19.78088155,"snippet":"Pharmacogenetics in the context of blood sugar focuses on genetic variants that influence response to diabetes medications. Key examples include TCF7L2 (metformin response), KCNJ11 (sulfonylureas), and CYP2C9 (sulfonylurea metabolism). Evidence from GWAS and clinical studies shows moderate effect sizes – for instance, metformin efficacy can vary by 20–30% depending on genotype. However, clinical implementation is not yet routine because the effects are small and often overshadowed by lifestyle, diet, and comorbidities. A commercial 'Pharmacogenetics Medicheck' can offer hypotheses but cannot replace medical diagnosis or treatment decisions. Predictive power for individual blood sugar traject","sources":[],"title":"Evidence check: Pharmakogenetik Medicheck in the context of Blutzucker","url":"https://tikki.wiki/wissen/gesundheit/frage/public-0eebbcb43fe140c7b4291485/evidence-check-pharmakogenetik-medicheck-in-the-context-of-blutzucker/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"The combination of an IgE allergy test with blood sugar levels is not supported by scientific evidence. IgE antibodies are specific to immediate allergic reactions (Type I) and have no direct role in glucose metabolism. The provided context contains no information linking allergy markers to blood sugar. Even if a test like 'AllergieCheck' is marketed, it is a commercial product without validated clinical relevance for metabolic parameters. Blood sugar is primarily influenced by diet, exercise, hormones (insulin, glucagon), and genetic factors such as TCF7L2 variants – not by IgE. Evidence: unclear. Caveat: Such combination tests can lead to misinterpretation and unnecessary dietary restrictions. For blood sugar analysis, established methods (fasting glucose, HbA1c, oral glucose tolerance test) and medical consultation are required.","area":"gesundheit","canonical_id":"gesundheit:canonical-777c11a0083f32da468169b2","id":"public-e1f1fa43800750b0d5322598","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Evidence check: AllergieCheck | IgE-Antikörper Test in the context of Blutzucker","score":19.75614073,"snippet":"The combination of an IgE allergy test with blood sugar levels is not supported by scientific evidence. IgE antibodies are specific to immediate allergic reactions (Type I) and have no direct role in glucose metabolism. The provided context contains no information linking allergy markers to blood sugar. Even if a test like 'AllergieCheck' is marketed, it is a commercial product without validated clinical relevance for metabolic parameters. Blood sugar is primarily influenced by diet, exercise, hormones (insulin, glucagon), and genetic factors such as TCF7L2 variants – not by IgE. Evidence: unclear. Caveat: Such combination tests can lead to misinterpretation and unnecessary dietary restricti","sources":[],"title":"Evidence check: AllergieCheck | IgE-Antikörper Test in the context of Blutzucker","url":"https://tikki.wiki/wissen/gesundheit/frage/public-e1f1fa43800750b0d5322598/evidence-check-allergiecheck-ige-antikoerper-test-in-the-context-of-blutzucker/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"Glucose is the primary blood sugar biomarker, measured routinely in clinical diagnostics for decades. The evidence linking elevated fasting glucose to diabetes mellitus is human-strong: it rests on large prospective cohorts, randomized trials, and international guidelines (e.g., WHO, ADA). A DNA test cannot measure glucose directly; it may provide weak associations to variants (e.g., TCF7L2), but these do not yield actionable recommendations without a blood value. Consumer tests offering glucose as a biomarker are useful, but interpretation requires context (fasting status, HbA1c, insulin). Caution: a single glucose reading says little about metabolic health. Combining it with other markers (e.g., HbA1c, triglycerides) is more informative. Evidence level: human-strong for glucose as a diagnostic tool, but marketing for genetic 'glucose predisposition' without a blood test.","area":"gesundheit","canonical_id":"gesundheit:canonical-fd6bee114e54577b0957b6f5","id":"public-007b5a1f292b886f6730d868","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Evidence check: Glukose in the context of Blutzucker","score":19.74775104,"snippet":"Glucose is the primary blood sugar biomarker, measured routinely in clinical diagnostics for decades. The evidence linking elevated fasting glucose to diabetes mellitus is human-strong: it rests on large prospective cohorts, randomized trials, and international guidelines (e.g., WHO, ADA). A DNA test cannot measure glucose directly; it may provide weak associations to variants (e.g., TCF7L2), but these do not yield actionable recommendations without a blood value. Consumer tests offering glucose as a biomarker are useful, but interpretation requires context (fasting status, HbA1c, insulin). Caution: a single glucose reading says little about metabolic health. Combining it with other markers ","sources":[],"title":"Evidence check: Glukose in the context of Blutzucker","url":"https://tikki.wiki/wissen/gesundheit/frage/public-007b5a1f292b886f6730d868/evidence-check-glukose-in-the-context-of-blutzucker/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"The query asks for an evidence check on a 'Cardio Risk Check' in the context of blood sugar. The provided knowledge contexts contain no specific information about such a test from MyBody-X. Blood sugar (especially fasting glucose, HbA1c) is a well-established cardiovascular risk factor used in clinical scores like PROCAM or SCORE. A direct DNA test for blood sugar-related genes (e.g., TCF7L2, GCKR) can theoretically indicate genetic predisposition, but its predictive power for individual cardiovascular risk is weak and heavily modulated by lifestyle. Without specific studies or product details, the evidence for a combined test integrating genetic markers and blood sugar is unclear. MyBody-X may offer such analyses, but validity must be assessed through independent clinical trials. Caveat: Not a substitute for medical risk assessment; blood sugar measurements should be standardized.","area":"gesundheit","canonical_id":"gesundheit:canonical-b21854b8c8a966240fb9461d","id":"public-a059a4a689fa774e4ef0f3c1","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Evidence check: Cardio Risk Check | Herz-Kreislauf Risiko-Test in the context of Blutzucker","score":19.72615505,"snippet":"The query asks for an evidence check on a 'Cardio Risk Check' in the context of blood sugar. The provided knowledge contexts contain no specific information about such a test from MyBody-X. Blood sugar (especially fasting glucose, HbA1c) is a well-established cardiovascular risk factor used in clinical scores like PROCAM or SCORE. A direct DNA test for blood sugar-related genes (e.g., TCF7L2, GCKR) can theoretically indicate genetic predisposition, but its predictive power for individual cardiovascular risk is weak and heavily modulated by lifestyle. Without specific studies or product details, the evidence for a combined test integrating genetic markers and blood sugar is unclear. MyBody-X ","sources":[],"title":"Evidence check: Cardio Risk Check | Herz-Kreislauf Risiko-Test in the context of Blutzucker","url":"https://tikki.wiki/wissen/gesundheit/frage/public-a059a4a689fa774e4ef0f3c1/evidence-check-cardio-risk-check-herz-kreislauf-risiko-test-in-the-context-of-blutzucker/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}}],"schema_version":"tikki.search-response.v1"}